Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Assessments benefits

Assessed benefits due to enhanced Ca absorption resulting from the addition of modest amounts of long-chain inulin enriched widi oligofructose in a balanced randomized crossover design. Ca Abs measured using dual-isotope methodology via the ratio of Ca with Ca (intravenous tracer) as it appeared in urine collected over 48 hr. [Pg.251]

Farrow, S. (2004). Using risk assessment, benefit-cost analysis, and real options to implement a precautionary principle. Risk Anal. 24(3) 727-738. [Pg.192]

Therapeutic Confirmatory Demonstrate/confirm efficacy. Establish safety profile. Provide an adequate basis for assessing benefit/risk relationship to support licensing. Establish dose-response relationship. Adequate and well-ontrolled studies to establish efficacy. Randomized parallel dose-response studies. Clinical safety studies. Studies of mortality/morbidity outcomes. Large simple trials. Comparative studies. [Pg.141]

Arthur P, Bahl P, Bhan MK, Kirkwood BR, Martines J, Moulton LH, Panny ME, Ram M, Ram M, Underwood B. Randomised trial to assess benefits and safety of vitamin A supplementation linked to immunisation in early infancy. WHO/CHD Immunisation-Linked Vitamin A Supplementation Study Group. Lancet 1998 352(9136) 1257-63. [Pg.896]

Methods and Examples for Assessing Benefit/Risk and Safety for New Drug Applications. In Proceedings of a DIA Workshop-, Drug Inf. J. 1993 Vol. 27, 1011-1049. [Pg.740]

Provide an adequate basis for assessing benefit risk Randomized parallel dose-response studies... [Pg.16]

The objective of clinical studies in the pharmaceutical industry is to assess whether a drug candidate will be effective in the treatment of a disease or condition, its risks of unwanted effects, and the relative relationship of these assessments (benefit/risk assessment). These studies must be conducted so that the participating volunteers (healthy subjects or patients) are exposed to the least possible risk consistent with the potential benefit, hi this context, clinical pharmacokinetics and pharmacodynamics in drug development is focused on three main objectives ... [Pg.75]

Graphs are an important aspect of quantif5ong benefit and risk. Statistical methods for benefit-risk are emerging as well. Worthy of particular note is a benefit-risk graph assessing benefits and risks within each patient over time. ... [Pg.216]

After the testing phase on RMM prototypal plant reported in this chapter, a comparison between the two configurations can be made in order to assess benefits and drawbacks in integrating selective membrane internally or externally. [Pg.214]

The ICH QIO guideline is developed as a PQS model for the whole life cycle of an industrially made product. It therefore starts with the design phase of the product and ends with product discontinuation. It does not include however the very first step the therapeutic issues (prescription assessment, benefit/risk balance) which are relevant for pharmacy preparations. [Pg.781]

Discounting the benefit of total elimination of the Cl release category over 60 years gives an assessed benefit of 75 0. The proposed enhancement would thus not be cost-effective, as it would require a disproportion factor of 29 to make it worthwhile. Thus there is an ALARP case for not including this potential design alternative. [Pg.377]

J.K. Aronson UK Observational studies in assessing benefits and harms Double standards ... [Pg.803]

Bottom hole assemblies and certain types of downhole equipment (e.g. logging tools, MWD tools) cost several US 100,000. Some logging tools will have radioactive sources which may need to be recovered or isolated for safety and legal reasons. However, prior to commencing fishing operations, a cost - benefit assessment will have to be made to establish that the time and equipment attributable to the fishing job is justified by the value of the fish or the cost of sidetracking the hole. [Pg.58]

The first results of computer-based assessment system application show that the benefits are obvious for repaired (without heat treatment) welds and complex defect configurations defect with height local increasing, group of defects, case analysis of defects interference and possible joining. [Pg.197]

The benefits of flaw visualization tools applications are supported by strength maintenance software, based on computer modelling and realizing assessment procedure. [Pg.197]

Alcohol Production. Studies to assess the costs of alcohol fuels and to compare the costs to those of conventional fuels contain significant uncertainties. In general, the low cost estimates iadicate that methanol produced on a large scale from low cost natural gas could compete with gasoline when oil prices are around 140/L ( 27/bbl). This comparison does not give methanol any credits for environmental or energy diversification benefits. Ethanol does not become competitive until petroleum prices are much higher. [Pg.423]

Benefits depend upon location. There is reason to beheve that the ratio of hydrocarbon emissions to NO has an influence on the degree of benefit from methanol substitution in reducing the formation of photochemical smog (69). Additionally, continued testing on methanol vehicles, particularly on vehicles which have accumulated a considerable number of miles, may show that some of the assumptions made in the Carnegie Mellon assessment are not vahd. Air quaUty benefits of methanol also depend on good catalyst performance, especially in controlling formaldehyde, over the entire useful life of the vehicle. [Pg.434]

Office of Pohcy, Planning, and Analysis, Assessment of Costs and Benefits ofElexible and Alternative Euel Use in the U.S. Transportation Sector, Technical Report 3 (Methanol Production and Transportation Costs) Pub. DOE/P/E—0093, U.S. Department of Energy, Washington, D.C., Nov. [Pg.435]

The assessment of the contribution of a product to the fire severity and the resulting hazard to people and property combines appropriate product flammabihty data, descriptions of the building and occupants, and computer software that includes the dynamics and chemistry of fires. This type of assessment offers benefits not available from stand-alone test methods quantitative appraisal of the incremental impact on fire safety of changes in a product appraisal of the use of a given material in a number of products and appraisal of the differing impacts of a product in different buildings and occupancies. One method, HAZARD I (11), has been used to determine that several commonly used fire-retardant—polymer systems reduced the overall fire hazard compared to similar nonfire retarded formulations (12). [Pg.451]

A proper assessment of the costs and benefits associated with standardization depends on having suitable baseline data with which to make a comparison. Several surveys have shown typical doUat returns for the investment in standardization in the range of 5 1—8 1 with occasional claims made for a ratio as high as 50 1. [Pg.21]

Process Hazards Analysis. Analysis of processes for unrecogni2ed or inadequately controUed ha2ards (see Hazard analysis and risk assessment) is required by OSHA (36). The principal methods of analysis, in an approximate ascending order of intensity, are what-if checklist failure modes and effects ha2ard and operabiHty (HAZOP) and fault-tree analysis. Other complementary methods include human error prediction and cost/benefit analysis. The HAZOP method is the most popular as of 1995 because it can be used to identify ha2ards, pinpoint their causes and consequences, and disclose the need for protective systems. Fault-tree analysis is the method to be used if a quantitative evaluation of operational safety is needed to justify the implementation of process improvements. [Pg.102]

Economic evaluation is an assessment of the probable benefit or reward of a proposed course of action, relative to other choices. Although the benefit usually takes the form of a financial return, in environmental management, transportation (qv), health care, and other social areas, the benefit may be a social gain instead. Some method is then developed to translate the social gain into a monetary equivalent. The discussion herein is limited to the financial return expected from some type of production or service activity. [Pg.441]


See other pages where Assessments benefits is mentioned: [Pg.68]    [Pg.350]    [Pg.178]    [Pg.934]    [Pg.68]    [Pg.350]    [Pg.178]    [Pg.934]    [Pg.1011]    [Pg.564]    [Pg.433]    [Pg.518]    [Pg.106]    [Pg.108]    [Pg.63]    [Pg.153]    [Pg.268]    [Pg.83]    [Pg.89]    [Pg.133]    [Pg.441]    [Pg.2164]    [Pg.2166]    [Pg.82]   
See also in sourсe #XX -- [ Pg.578 ]




SEARCH



Benefit design targeting assessment

Cost benefit assessment

Cost-benefit analysis risk assessment

Decision-making process cost/benefit assessments

Drugs risk-benefit assessment

Economic benefits assessment

Health issues risk-benefit assessments

Informed consent benefit-risk assessment

Pharmaceuticals clinical benefit assessment

Probabilistic risk assessment benefits

Quantitative Cost-Benefit Assessments

Risk-benefit assessment

© 2024 chempedia.info